Cost Benefit Analysis of the eHealth Platform in Germany

Cost Benefit Analysis

of the eHealth Platform in Germany

ePrescription and HealthCard:Synergies of an optimal Solution

3rd Annual EHTEL Conference

Delivering eHealth Across Europe

Bruges 2002

Andreas Lux

Advice Company for Information Technology and Organization in Health Care Systems Hamburg

Debold & Lux

Ehtel 2002 Folie 2CBA - eHealth Platform

Scope and Intentionof the Cost-Benefit-Analysis

Communication Platform in Health Care Implementing an Infrastructure

Assistance with Applications Mass application In daily use of all Health Professionals Easy telematic realisation Expected financial contribution

The identified Applications are: New Health Insurance Card (HIC) with online update Electronic Prescription (EP) of Drugs Medication History Documentation (MHD) with Screening

Debold & Lux

Debold & Lux


Agenda

Benefit

Costs

Allocation of costs and benefits

Results

Debold & Lux

Debold & Lux


Health Insurance Card Savings in the business processes

High legitimation of the insured persons yearly 18 Mio. new insurance cards,

nevertheless only a mistake in 0,25 – 0,35 % of the cases Misallocation is economical irrelevant (inside the compulsory

insurance system)

The costs of the maintenance of the old HIC are savings – 24 million € per year

Great failure in the handling of the relieving Co-Payment

it doesn't work - insured persons with a relieving pays and insured persons without a relieving don‘t pay

Debold & Lux

Debold & Lux


Relieving from Co-paymentProjection in comparison

Annual deficit for the compulsory health insurance companies (Projection)

225

257 260

0

50

100

150

200

250

300

Mill

ion

Eu

ro

AOK H AOK Sachsen GEK

153

Debold & Lux

Debold & Lux

used inthe CBA


Saving potential of the ePrescriptionTransaction Costs

EP - Paper Administration 5 Mio. €

EP - Image Administration 20 Mio. €

Improvement of the prescription proof 75 Mio. €

Providing physicians with EP forms 5 Mio. €

Reducing administrative costs in pharmacies 40 Mio. €

Debold & Lux

Debold & Lux


Medication History Documentation (MHD)

Model Calculation and estimated in the CBA

Only hospital costs

Ambulant treatment costs are not included

No, estimations regarding economic effects, like loss of working days

Reasons for the reduced benefit in the CBA calculation Application is voluntary for the

patient Application is voluntary for

physicians and pharmacists The quality of the reaction in the

use of warning information isn’t proofed

128

551

0

100

200

300

400

500

600

Result DHD

Million

€

Result

Estimated

Debold & Lux

Debold & Lux


Debold & Lux

Debold & Lux

A B C D E

24 24

77

153

128

41

50

50

100

150

Mill

ion

€

Physicians

Pharmacists

Insurances.

A Paper Forms B HIC old

C Billing Proof D Co-Payment E Medication History Documentation

SavingsAmount and Allocation

551

260


Investment 559 Mio. €

1499

143

187

116

0

100

200

300

400

500

600

Mil

lio

n €

Education

Insurance Card

InfrastructureCommunication

PKI

Project

Debold & Lux

Debold & Lux

- Working hours physician / staff- direct education costs

- Chipcard for the insured people

- Server Routing/Transport/HI- Communication server with

Firewall physicians/pharmacists

- HPC for Health Professionals- Card terminals

- Planning and concept- Realisation of a pilot

(ca. 100.000 insured people)


Accumulation of Costs and SavingsBreak Even Point (BEP)

Debold & Lux

Debold & Lux

Mill

ion

€

0

500

1.000

1.500

year 0 year 1 year 2 year 3 year 4 year 5

Investment

Running Costs

Savings

S+Co-Payment

S+Co+MHDBEP


Allocation of Costs and Benefit

Debold & Lux

Debold & Lux

InsurancesPhysicians

Pharmacists

Running Costs in 5 years

Investment

Savings in 5 years

2023

26

204227 28745

125 19262

0

200

400

600

800

1.000

1.200

1.400

1.600

1.800

2.000

mil

lio

n €


Resultinfrastructure, economical and health political

Liability is given, security infrastructure is implemented

A refinancing of the investment is possible

The medical applications will have the biggest potential, the administrative applications are only starter

Political acceptance for this model requires,

Balance of the asymmetric allocation of costs and benefits

Benefit from the new technology not only for the health insurance companies, but also for physicians and patients

Debold & Lux

Debold & Lux


Contact and more Information

The complete Cost-Benefit-Analysis is available in German language and a short summery in English on the following links.

www.Debold-Lux.com

Sponsors of the Study:

Federal Union of German Associations of Pharmacists – ABDA

www.abda.de

Verband der Angestellten-Krankenkassen e.V. - VdAK, Siegburg

www.vdak.de

Debold & Lux

Debold & Lux


Are the results transferable?

Debold & Lux

Debold & Lux

Costs

The results are transferable in the most European countries

Benefits New Health Insurance Card

Special situation in Germany

Electronic Prescription of Drugs

There should be an equal situation in other countries. The administrative processes for clearing and proof became more efficiency

Medication History

Equal situation and effects in other countries

Cost Benefit Analysis of the eHealth Platform in Germany

Documents

Transcript of Cost Benefit Analysis of the eHealth Platform in Germany